The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Ray Manneh-Kopp
Leadership - Sociedad de Oncología y Hematología del Cesar (I)
Honoraria - Amgen; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi; Tecnofarma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Tecnofarma
Speakers' Bureau - Asociación Colombiana de Hematoligía y Oncología (ACHO); San Jorge Foundation
Research Funding - Amgen; Bristol-Myers Squibb/Celgene; Merck Sharp & Dohme; Novartis; Pfizer
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme; Pfizer; Roche/Genentech
 
Camila Lema
No Relationships to Disclose
 
Beatriz Preciado
Speakers' Bureau - Bristol-Myers Squibb/Pfizer (I); Janssen Oncology (I); MSD Oncology (I); Roche (I)
Research Funding - Abbott Laboratories (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Janssen Oncology (I); MSD Oncology (I)
 
Rafael Quintana
Employment - Merck
Honoraria - Merck
 
Mauricio Lema
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Dr. Reddy's Laboratories; Johnson & Johnson/Janssen; Knight Pharmaceuticals; Lilly; MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Lilly; MSD Oncology; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Medarex (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Adium Pharma; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb/Medarex; Johnson & Johnson/Janssen; MSD Oncology; Roche
 
Emilio Pérez
No Relationships to Disclose
 
Mateo Pineda
No Relationships to Disclose
 
Ivan Bustillo
Employment - Clinica Portoazul - Auna
 
Sebastian Saleh
No Relationships to Disclose
 
Ana Garcia
Speakers' Bureau - Astellas Amgen BioPharama; Ipsen; Janssen
Research Funding - MSD
Travel, Accommodations, Expenses - Adium Pharma; Ipsen; Janssen
 
Maycos Zapata
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; Lilly; Merck Serono; MSD Oncology; Novartis
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb/Medarex; Janssen Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Roche
Research Funding - MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Merck Serono; MSD Oncology; Roche
 
Laura Bernal
Stock and Other Ownership Interests - Idime
Honoraria - Astellas Pharma; AstraZeneca; Bayer; bristol-mayers-squibb; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Tecnofarma
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Janssen; MSD; Pfizer
Speakers' Bureau - AstraZeneca; Bayer; Bristol-mayers-squibb; Ipsen; Janssen; MSD
Research Funding - GlaxoSmithKline; MSD
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Janssen; MSD; Pfizer